Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:221-223

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loscalzo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loscalzo, J.
Related Collections
Right arrow Animal models of human disease
Right arrow Pathophysiology
Right arrow CV surgery: coronary artery disease
Right arrow Gene therapy

(Circulation. 2000;101:221.)
© 2000 American Heart Association, Inc.


Editorials

Vascular Matrix and Vein Graft Failure

Is the Message in the Medium?

Joseph Loscalzo, MD, PhD

From the Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass.

Correspondence to Joseph Loscalzo, MD, PhD, Boston University School of Medicine, Whitaker Cardiovascular Institute, 715 Albany St, W507, Boston, MA 02118. E-mail jloscalz@bu.edu


Key Words: Editorials • veins • revascularization • atherosclerosis • grafting

The pioneering work of Favaloro1 established the era of surgical revascularization for the treatment of ischemic heart disease. The benefits of this procedure were recognized early, and the use of the saphenous vein as a bypass conduit rapidly gained widespread acceptance as an effective treatment for angina. However, surgical revascularization has significant shortcomings, principal among which is the high rate of accelerated atherosclerosis that develops in vein grafts: at 10 years after surgery, 40% of grafts are occluded and only 50% are free of significant disease.2

Vein graft failure is a consequence of three related processes. Early after implantation, thrombosis plays a critical role, both by predisposing to acute occlusion and by serving as a stimulus for neointima formation and, ultimately, graft atherosclerosis. Within 6 weeks after implantation, virtually all arterialized vein grafts develop intimal hyperplasia, which, although it only modestly compromises the lumen of the graft, renders the graft susceptible to atherosclerosis.3 The cellular events that account for this intimal response include migration and proliferation of vascular smooth muscle cells, perhaps derived from adventitial fibroblasts (myofibroblasts),4 followed by extracellular matrix synthesis and deposition. This latter process ultimately leads to progressive intimal fibrosis with relatively reduced intimal cellularity.5

Vein grafts are susceptible to intimal hyperplasia and atherosclerosis for two main reasons. First, explanted vein grafts are prone to vessel wall ischemia owing to a loss of functional vasa vasorum; regrowth of these nutrient vessels appears as early as 5 days after graft placement, but a rich network sufficient to provide . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Misra, A. A. Fu, A. Puggioni, K. M. Karimi, J. N. Mandrekar, J. F. Glockner, L. A. Juncos, B. Anwer, A. M. McGuire, and D. Mukhopadhyay
Increased shear stress with upregulation of VEGF-A and its receptors and MMP-2, MMP-9, and TIMP-1 in venous stenosis of hemodialysis grafts
Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2219 - H2230.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Mayranpaa, J. Simpanen, M. W. Hess, K. Werkkala, and P. T. Kovanen
Arterial endothelial denudation by intraluminal use of papaverine-NaCl solution in coronary bypass surgery
Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 560 - 566.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. A. Nath, S. K. R. Kanakiriya, J. P. Grande, A. J. Croatt, and Z. S. Katusic
Increased Venous Proinflammatory Gene Expression and Intimal Hyperplasia in an Aorto-Caval Fistula Model in the Rat
Am. J. Pathol., June 1, 2003; 162(6): 2079 - 2090.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
T. Giesler, U. Baum, D. Ropers, S. Ulzheimer, E. Wenkel, M. Mennicke, W. Bautz, W. A. Kalender, W. G. Daniel, and S. Achenbach
Noninvasive Visualization of Coronary Arteries Using Contrast-Enhanced Multidetector CT: Influence of Heart Rate on Image Quality and Stenosis Detection
Am. J. Roentgenol., October 1, 2002; 179(4): 911 - 916.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
C. Hong, C. R. Becker, A. Huber, U. J. Schoepf, B. Ohnesorge, A. Knez, R. Bruning, and M. F. Reiser
ECG-gated Reconstructed Multi-Detector Row CT Coronary Angiography: Effect of Varying Trigger Delay on Image Quality
Radiology, September 1, 2001; 220(3): 712 - 717.
[Abstract] [Full Text] [PDF]


Home page
SEMIN CARDIOTHORAC VASC ANESTHHome page
S. L. Meyerson, C. L. Skelly, M. A. Curi, and L. B. Schwartz
Gene Therapy for Cardiovascular Disease
Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 2000; 4(4): 289 - 300.
[Abstract] [PDF]